Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
0
Authors
Kewen He
14 more
Kewen He
•
Nahum Puebla‐Osorio
12 more
•
James Welsh
Published
September 2, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Experimental & Clinical Cancer Research
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1186/s13046-024-03165-x
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Experimental & Clinical Cancer Research
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1186/s13046-024-03165-x
License
CC-BY
